↓ Skip to main content

Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report

Overview of attention for article published in Cardiovascular Diabetology, September 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

blogs
1 blog

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
48 Mendeley